Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spotify
SPOT
|
+$767M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$720M |
| 3 |
Philip Morris
PM
|
+$535M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$396M |
| 5 |
CVET
Covetrus, Inc. Common Stock
CVET
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$3.39B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.26B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.04B |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$984M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.68% |
| 2 | Healthcare | 9.97% |
| 3 | Financials | 8.83% |
| 4 | Consumer Discretionary | 7.6% |
| 5 | Communication Services | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Innoviva
INVA
$1.58B
| $1.28M | ﹤0.01% |
91,315
-278,065
| -75% | -$4.5M |
|
|
TARO
3852
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.28M | ﹤0.01% |
11,824
+3,672
| +45% | +$366K |
|
3853
MYR Group
MYRG
$5.2B
| $1.28M | ﹤0.01% |
36,901
+11,047
| +43% | +$360K |
|
3854
Gladstone Capital
GLAD
$442M
| $1.27M | ﹤0.01% |
70,752
+1,166
| +2% | +$20.5K |
|
3855
Ingles Markets
IMKTA
$1.67B
| $1.27M | ﹤0.01% |
46,093
-12,357
| -21% | -$363K |
|
|
CCF
3856
DELISTED
Chase Corporation
CCF
| $1.27M | ﹤0.01% |
13,747
+659
| +5% | +$62.7K |
|
3857
El Paso Energy Capital Trust I
EP.PRC
$221M
| $1.27M | ﹤0.01% |
23,673
-324
| -1% | -$15.6K |
|
3858
HUTCHMED
HCM
$2.02B
| $1.27M | ﹤0.01% |
41,492
-10,607
| -20% | -$265K |
|
3859
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$678M
| $1.26M | ﹤0.01% |
42,699
-3,861
| -8% | -$114K |
|
3860
Invesco Next Gen Media and Gaming ETF
GGME
$45.3M
| $1.26M | ﹤0.01% |
38,806
-14,282
| -27% | -$454K |
|
|
CATC
3861
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.26M | ﹤0.01% |
15,173
-7,122
| -32% | -$569K |
|
|
QTNA
3862
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $1.26M | ﹤0.01% |
51,617
-58,010
| -53% | -$1.01M |
|
|
FSNN
3863
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
| $1.25M | ﹤0.01% |
956,492
-29,225
| -3% | -$52.1K |
|
|
PNF
3864
DELISTED
PIMCO New York Municipal Income Fund
PNF
| $1.25M | ﹤0.01% |
94,557
-3,494
| -4% | -$45K |
|
|
GPX
3865
DELISTED
GP Strategies Corp.
GPX
| $1.25M | ﹤0.01% |
103,097
-12,645
| -11% | -$185K |
|
3866
TherapeuticsMD
TXMD
$23.5M
| $1.25M | ﹤0.01% |
5,137
-4,602
| -47% | -$1.22M |
|
|
ZTR
3867
Virtus Total Return Fund
ZTR
$339M
| $1.25M | ﹤0.01% |
116,821
-2,392
| -2% | -$24.5K |
|
|
BRSP
3868
BrightSpire Capital
BRSP
$638M
| $1.25M | ﹤0.01% |
79,824
-91,310
| -53% | -$1.5M |
|
|
ACV
3869
Virtus Diversified Income & Convertible Fund
ACV
$282M
| $1.25M | ﹤0.01% |
55,144
-4,320
| -7% | -$92.8K |
|
|
BKS
3870
DELISTED
Barnes & Noble
BKS
| $1.25M | ﹤0.01% |
229,830
-671,842
| -75% | -$4.09M |
|
|
ALEX
3871
DELISTED
Alexander & Baldwin
ALEX
| $1.25M | ﹤0.01% |
48,953
-104,442
| -68% | -$2.4M |
|
3872
Aclaris Therapeutics
ACRS
$887M
| $1.24M | ﹤0.01% |
206,755
+39,712
| +24% | +$263K |
|
|
IPFF
3873
DELISTED
iShares International Preferred Stock ETF
IPFF
| $1.24M | ﹤0.01% |
79,817
-9,313
| -10% | -$146K |
|
3874
CytomX Therapeutics
CTMX
$729M
| $1.23M | ﹤0.01% |
114,764
+30,385
| +36% | +$449K |
|
|
ALIM
3875
DELISTED
Alimera Sciences
ALIM
| $1.23M | ﹤0.01% |
77,601
-26
| -0% | -$396 |
|
Similar funds
Morgan Stanley's Q1 2019 Portfolio in Review
As of Q1 2019, Morgan Stanley held 6,971 positions worth $353B, up 5.7% from $334B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley withdrew a net $29.7B in Q1 2019, closing 194 positions and reducing 3,763 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $984M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Morgan Stanley opened a new position in Covetrus, Inc. Common Stock worth $335M.
- Morgan Stanley's largest Q1 2019 buy was Covetrus, Inc. Common Stock: 10,522,945 shares worth $335M.
- Morgan Stanley added most to Spotify in Q1 2019, an estimated $767M increase.
- Morgan Stanley's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $3.39B.
- Morgan Stanley fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $984M.
- Morgan Stanley's ten largest holdings make up 14% of its $353B portfolio in Q1 2019.
- Morgan Stanley opened 157 new positions and closed 194 in Q1 2019.
- Morgan Stanley's portfolio value rose 5.7% quarter-over-quarter to $353B.
Based on Morgan Stanley's 13F filing for Q1 2019, filed 15 May 2019.